tradingkey.logo
搜索

Intelligent Bio Solutions Inc

INBS
添加自选
1.805USD
+0.230+14.60%
收盘 07-31 16:00美东报价延迟15分钟
3.61M总市值
亏损市盈率 TTM

关于 Intelligent Bio Solutions Inc 公司

Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.

Intelligent Bio Solutions Inc简介

公司代码INBS
公司名称Intelligent Bio Solutions Inc
上市日期Dec 23, 2020
CEOSimeonidis (Harry)
员工数量16
证券类型Ordinary Share
年结日Dec 23
公司地址135 W 41St St,
城市NEW YORK
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编10036
电话16467905756
网址https://ibs.inc/
公司代码INBS
上市日期Dec 23, 2020
CEOSimeonidis (Harry)

Intelligent Bio Solutions Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
34.54K
+88.30%
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
5.01K
+99.88%
Mr. Jason Isenberg
Mr. Jason Isenberg
Independent Director
Independent Director
5.00K
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
5.00K
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Managing Director
Managing Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
34.54K
+88.30%
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
5.01K
+99.88%
Mr. Jason Isenberg
Mr. Jason Isenberg
Independent Director
Independent Director
5.00K
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
5.00K
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--

常见问题

Intelligent Bio Solutions Inc的前五大股东是谁?

Intelligent Bio Solutions Inc 的前五大股东如下:Mr. Harry Simeonidis

有多少机构持有Intelligent Bio Solutions Inc(INBS)的股份?

截至2026Q1,共有29家机构持有Intelligent Bio Solutions Inc的股份,合计持有的股份价值约为1.95K,占公司总股份的0.09%。与2025Q4相比,机构持股有所增加,增幅为-189189.00。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有